E-LIB Suche - Ergebnisse für: Das, Anita F

1

P29 Treatment outcomes with rezafungin and caspofungin in p..:

Cornely, Oliver A ; Thompson, George R ; Soriano, Alex...
JAC-Antimicrobial Resistance. 6 (2024) Supplement_1 - p. , 2024

Link: https://doi.org/10.1093/..

2

Efficacy and safety of rezafungin and caspofungin in candid..:

Thompson III, George R ; Soriano, Alex ; Honore, Patrick M...
The Lancet Infectious Diseases. 24 (2024) 3 - p. 319-328 , 2024

Link: https://doi.org/10.1016/..

3

Outcomes byCandidaspp. in the ReSTORE Phase 3 trial of reza..:

Locke, Jeffrey B. ; Pillar, Chris M. ; Castanheira, Mariana...
Antimicrobial Agents and Chemotherapy. 68 (2024) 5 - p. , 2024

Link: https://doi.org/10.1128/..

4

Exebacase in Addition to Standard-of-Care Antibiotics for S..:

Fowler Jr, Vance G ; Das, Anita F ; Lipka-Diamond, Joy...
Clinical Infectious Diseases. 78 (2024) 6 - p. 1473-1481 , 2024

Link: https://doi.org/10.1093/..

5

Efficacy and Safety of Adintrevimab (ADG20) for the Treatme..:

Ison, Michael G ; Popejoy, Myra ; Evgeniev, Nikolay...
Open Forum Infectious Diseases. , 2023

Link: https://doi.org/10.1093/..

6

Applying Desirability of Outcome Ranking End Points:

Dunne, Michael W ; Aronin, Steven I ; Das, Anita F...
Clinical Infectious Diseases. 77 (2023) 1 - p. 159-161 , 2023

Link: https://doi.org/10.1093/..

7

Rezafungin versus caspofungin for treatment of candidaemia ..:

Thompson III, George R ; Soriano, Alex ; Cornely, Oliver A...
The Lancet. 401 (2023) 10370 - p. 49-59 , 2023

Link: https://doi.org/10.1016/..

8

Applying Desirability of Outcome Ranking End Point to Rando..:

Dunne, Michael W ; Aronin, Steven I ; Das, Anita F...
Clinical Infectious Diseases. 76 (2023) 12 - p. 2213-2215 , 2023

Link: https://doi.org/10.1093/..

9

Sulopenem for the Treatment of Complicated Urinary Tract In..:

Dunne, Michael W ; Aronin, Steven I ; Das, Anita F...
Clinical Infectious Diseases. 76 (2022) 1 - p. 78-88 , 2022

Link: https://doi.org/10.1093/..

10

231. Outcomes by Baseline Pathogen and Susceptibility in th..:

Thompson, George R ; Soriano, Alex ; Cornely, Oliver A...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

11

Sulopenem or Ciprofloxacin for the Treatment of Uncomplicat..:

Dunne, Michael W ; Aronin, Steven I ; Das, Anita F...
Clinical Infectious Diseases. 76 (2022) 1 - p. 66-77 , 2022

Link: https://doi.org/10.1093/..

12

Pooled microbiological findings and efficacy outcomes by pa..:

Paukner, Susanne ; Goldberg, Lisa ; Alexander, Elizabeth...
Journal of Global Antimicrobial Resistance. 29 (2022) - p. 434-443 , 2022

Link: https://doi.org/10.1016/..

13

Clinical Efficacy of Patients With Secondary Bacteremia Tre..:

Sakoulas, George ; Eckburg, Paul B ; Amodio-Groton, Maria...
Open Forum Infectious Diseases. 8 (2021) 6 - p. , 2021

Link: https://doi.org/10.1093/..

14

Omadacycline vs moxifloxacin in adults with community-acqui..:

Torres, Antoni ; Garrity-Ryan, Lynne ; Kirsch, Courtney...
International Journal of Infectious Diseases. 104 (2021) - p. 501-509 , 2021

Link: https://doi.org/10.1016/..

15

Lefamulin efficacy and safety in a pooled phase 3 clinical ..:

File Jr., Thomas M. ; Alexander, Elizabeth ; Goldberg, Lisa...
BMC Pulmonary Medicine. 21 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..